CLB Stock Recent News
CLB LATEST HEADLINES
Crude price is now in its glorious days, calling for investment in energy companies like Matador Resources (MTDR), Pioneer Natural (PXD) and Core Laboratories (CLB).
The decisions of Saudi Arabia & Russia to voluntarily extend oil cuts until the year-end are aiding the crude rally. Solaris (SOI), Core Lab (CLB) and Evolution (EPM) are thus well-poised to gain.
Core Laboratories (CLB) anticipates revenues and operating income in the range of $128-$132 million and $15.2-$17.5 million, respectively, with earnings in the band of 21-25 cents per share for Q3 2023.
The headline numbers for Core Laboratories (CLB) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.12 per share a year ago.
Business is improving for Core Laboratories Inc. at a very modest incremental pace. The company lacks a moat or a near-term catalyst.
Core Labs (CLB) expects second-quarter 2023 revenues of $130-$135 million, earnings of 20-24 cents per share and operating income of $14.5-$17.5 million.
Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript.
Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.08 per share a year ago.
Eight members of OPEC+ decided to cut their oil production by a combined 1.16 million barrels per day. The move follows a 2 million barrel per day OPEC+ cut back in October.